Frank BurrellScientific Storytelling
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Suma Ramadas, PhDMedical Affairs
Pat PurcellMeeting Engagement
Paul TheisenPatient Acquisition
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Matthew DurhamOmnidynamic Marketing
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Matt TurnerPatient Affordability
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Dupixent® (dupilumab) showed positive Phase 3 ...
Sandoz is seeking approval of proposed biosimilar adalimumab for use in all reference medicine ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email